A comprehensive view of Shionogi & Co. Ltd.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Shionogi and The AIDS Clinical Trials Group to initiate global Phase 3 clinical trial for a COVID-19 antiviral agent; trail is funded by US National Institutes of Health
Published: March 24, 2022 by CDC & FDA Daily
Shionogi files for approval in Japan for S-217622, a therapeutic drug for COVID-19; treatment is an orally administered antiviral
Published: February 25, 2022 by Shionogi & Co. Ltd.
Shionogi reports its experimental COVID-19 antiviral effective in clinical trials; high dose makes patients 80% less likely to shed virus four days after administration
Published: February 02, 2022 by The Peninsula
DSL Japan, a joint venture of Evonik and Shionogi launch new production line for specialty silicas at site in Ako, Japan, expanding capacity by 30%; production supports growing demand domestically and abroad
Published: October 25, 2021 by Evonik Industries AG

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count